INTANGIBLE ASSETS AND GOODWILL (Tables)

6 Months Ended

Jun. 30, 2020

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of net-book value and estimated remaining life and finite lived intangible assets

The following table summarizes the net-book-value and estimated remaining life of the Company’s intangible assets as of June 30, 2020:​

(In thousands)	Weighted Average Remaining Life (Years)	Cost		Accumulated Amortization		Net Balance at June 30, 2020
Finite-lived intangible assets
Trade name	15.4	$	100,700	$	(4,109)	$	96,591
Customer relationships	13.3	2,700		(314)		2,386
Patents	8.4	22,689		(7,105)		15,584
Acquired developed technology	9.5	814,171		(52,766)		761,405
Supply agreements	7.0	30,000		(2,549)		27,451
Internally developed technology	2.3	1,796		(590)		1,206
Total finite-lived intangible assets		972,056		(67,433)		904,623
In-process research and development	n/a	200,000		—		200,000
Internally developed technology in process	n/a	492		—		492
Total intangible assets		$	1,172,548	$	(67,433)	$	1,105,115

The following table summarizes the net-book-value and estimated remaining life of the Company’s intangible assets as of December 31, 2019:​

(In thousands)	Weighted Average Remaining Life (Years)	Cost		Accumulated Amortization		Net Balance at December 31, 2019
Finite-lived intangible assets
Trade name	15.9	$	100,700	$	(961)	$	99,739
Customer relationships	13.6	2,700		(224)		2,476
Patents	8.8	22,690		(5,974)		16,716
Acquired developed technology	9.9	806,371		(12,345)		794,026
Supply agreements	7.5	30,000		(571)		29,429
Internally developed technology	2.5	1,229		(336)		893
Total finite-lived intangible assets		963,690		(20,411)		943,279
In-process research and development	n/a	200,000		—		200,000
Internally developed technology in process	n/a	271		—		271
Total intangible assets		$	1,163,961	$	(20,411)	$	1,143,550

Schedule of estimated future amortization expense, intangible assets

As of June 30, 2020, the estimated future amortization expense associated with the Company’s finite-lived intangible assets for each of the five succeeding fiscal years is as follows:​

(In thousands)
2020	$	47,158
2021	94,217
2022	94,012
2023	93,724
2024	93,345
Thereafter	482,167
​	$	904,623

Schedule of Carrying Amount of Goodwill

The change in the carrying amount of goodwill for the periods ended June 30, 2020 and December 31, 2019 is as follows:

(In thousands)
Balance, January 1, 2019	$	17,279
Genomic Health acquisition	1,185,918
Balance, December 31, 2019	1,203,197
Paradigm & Viomics acquisition	30,431
Genomic Health acquisition adjustment	4,044
Balance, June 30, 2020	$	1,237,672